stockrowOscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.
- Revenue
- +72.1%
- EPS
- +201.9%
- Free cash flow
- −24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow OSCR
Alert me
Oscar Health, Inc. (OSCR) EBITDA
Oscar Health, Inc.'s EBITDA for fiscal 2025 was −$395.6M, compared with $63.3M in fiscal 2024. Over the twelve months to 30 June 2026 it was $632.0M. Over the past ten years it has ranged from −$571.4M (fiscal 2022) to $63.3M (fiscal 2024); the current reading is higher than 43% of that period. Oscar Health, Inc. ranks 7th of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | −$395.6M | — |
| FY2024 | $63.3M | — |
| FY2023 | −$233.5M | — |
| FY2022 | −$571.4M | — |
| FY2021 | −$521.5M | — |
| FY2020 | −$388.1M | — |
| FY2019 | −$259.1M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $387.6M | (45.02%) |
| Mar 2026 | $705.0M | — |
| Dec 2025 | −$331.7M | — |
| Sep 2025 | −$129.0M | — |
| 22 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| CI Cigna Group compare | $12.7B |
| ELV Elevance Health, Inc. compare | $9.2B |
| HUM Humana Inc. compare | $3.1B |
| CNC Centene Corporation compare | $2.2B |
| OSCR Oscar Health, Inc. | $632.0M |
| MOH Molina Healthcare, Inc compare | $333.0M |
| PGNY Progyny, Inc. compare | $117.9M |
| ALHC Alignment Healthcare, Inc. compare | $76.7M |
| CLOV Clover Health Investments, Corp. compare | $12.7M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on OSCR
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement